title: Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis.
authors.affiliation: Brigham and Women's Hospital, The Vascular Disease Prevention Program Cardiovascular Division, Boston, USA.
authors.forename: J
authors.initials: J
authors.lastname: Plutzky
authors.affiliation: Baylor College of Medicine, Endocrinology, Houston, USA.
authors.forename: A
authors.initials: A
authors.lastname: Garber
authors.affiliation: Novo Nordisk, Biostatistics, Bagsvaerd, Denmark.
authors.forename: A
authors.initials: A
authors.lastname: Falahati
authors.affiliation: Novo Nordisk, Liraglutide Medical Affairs, Bagsvaerd, Denmark.
authors.forename: A D
authors.initials: AD
authors.lastname: Toft
authors.affiliation: Imperial College, Preventive Cardiovascular Medicine, London, United Kingdom.
authors.forename: N R
authors.initials: NR
authors.lastname: Poulter